Skip to main content
Start triage

Start triage first, then route to emergency care.

Need urgent help? Start triage first, then route to emergency care.

Meds A-Z

Amitraz

Detailed information about Amitraz

Official label facts Owner quick guide first Marketing clearly labeled

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Reviewed / Updated / Sources

Reviewed: Not available

Updated: February 12, 2026, 10:44 PM UTC

Sources:

Pet Owner Quick Guide

Start here first for the simple next-step summary.

Used for:

For the treatment of generalized demodicosis (Demodex canis).

What to watch for:

  • Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied
  • Do not use for treatment of localized demodicosis or scabies
  • wobbly/unsteady walking (1 reports)
  • Syncope (1 reports)
  • Stomach upset (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Safety & side effects

What to watch:

  • Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied
  • Do not use for treatment of localized demodicosis or scabies
  • wobbly/unsteady walking
  • Syncope
  • Stomach upset

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Syncope (1 reports)
  • Stomach upset (1 reports)

When to call your vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.

Data freshness: source data appears current.

Latest refresh: Mar 21, 2026, 10:01 a.m.

Data freshness
  • Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Feb 9, 2026, 3:15 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Image coming soon
Amitraz

Amitraz

Drug type: Generic ingredient • Branded profile FDA branded products available

Species: Both

Manufacturer: Not available (source)

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Not available
Form: Liquid
Identifiers:
NADA: 120299
Source metadata:

Warnings / Contraindications

Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied. Do not use for treatment of localized demodicosis or scabies. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • High: Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied. Do not use for treatment of localized demodicosis or scabies. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
27
Reported cases
22
Serious reports
13
Species represented
1
Grouped by Body System
Digestive (2) · Loss of appetite, Vomiting Skin & allergy (2) · Itching, Alopecia general Neurologic (3) · Unsteady walking (ataxia), Tiredness (lethargy), Lethargy (see also Central nervous system depression in 'Neurological') Behavior (2) · Biting -aggression, Behavioral disorder (unspecified) Effectiveness (3) · Lack of efficacy (endoparasite) - NOS, Lack of efficacy (ectoparasite) - tick NOS, Lack of efficacy (ectoparasite) - flea Other (15) · Weight gain, Syncope, Stomach upset
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Effectiveness 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Dog (27)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Other Dog Non-serious - 1
Neurologic Dog Serious - 1
Neurologic Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Digestive Dog Non-serious - 1
Effectiveness Dog Non-serious - 1
Effectiveness Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Behavior Dog Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Digestive Dog Unknown - -
Neurologic Dog Unknown - -
Effectiveness Dog Unknown - -
Skin & allergy Dog Unknown - -
Skin & allergy Dog Unknown - -
Source metadata:

Documents

Owner handouts and official technical documents are grouped for faster access.

Owner handouts (0)
  • No owner handouts linked yet.
Official label / PI (0)
  • No official label or package insert links yet.
SPL (1)
  • Mitaban® Liquid Concentrate · SPL
    https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1751/Mitaban%C2%AE%20Liquid%20Concentrate
FOI (0)
  • No FOI links yet.
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Feb 9, 2026, 3:15 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Mitaban® Liquid Concentrate
Case-reported brands (openFDA): MSK
Catalog species: Both FDA-labeled species: Dog
Rx/OTC: RX
Form/route: Liquid Topical
Applications: NADA 120-299
Documents: • SPL: 1 Label highlights Official documents
Safety (openFDA)
Top reactions: Dog 8 Cat 0 View
Case summaries: 5 (showing 5) View
openFDA reports are unverified and do not prove causation.

Explore
Related conditions: Demodicosis
Linked using: Fda_Label (0.95)

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied. Do not use for treatment of localized demodicosis or scabies. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Syncope (1) Stomach upset (1) Polyneuritis (1) Lack of efficacy (ectoparasite) - tick NOS (1) Drug administration error (1) Dilated pupils (1) Death by euthanasia (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NADA: 120299

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 3 Clinical 0 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied. Do not use for treatm… (Official, 2026-02-12)
  • side_effects: Top reported reactions (openFDA): Lethargy (see also Central nervous system depression in 'Neurological'), Pruritus, Vomiting, Drug administration error, Alope… (Official, 2026-02-12)
  • usage: For the treatment of generalized demodicosis (Demodex canis). (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Mitaban® Liquid Concentrate
RX
Amitraz
Liquid Topical
Zoetis Inc. NADA 120-299 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Amitraz liquid contains 19.9 percent amitraz in an organic solvent.
Dogs
Indication
For the treatment of generalized demodicosis (Demodex canis).
Dosage
One 10.6 milliliter bottle per 2 gallons of warm water (250 parts per million) for each treatment, for a total of 3 to 6 treatments, 14 days apart.
Limitations
Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied. Do not use for treatment of localized demodicosis or scabies. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Official Documents (FDA)

Direct links to FDA-hosted PDFs and SPL packages (when available).

Usage

For the treatment of generalized demodicosis (Demodex canis).

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Continue treatment until no viable mites are found in skin scrapings at 2 successive treatments, or until 6 treatments have been applied. Do not use for treatment of localized demodicosis or scabies. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Dog Vomiting • Dog

Showing top 5 for Digestive.

Skin & allergy
Itching • Dog Alopecia general • Dog

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog Tiredness (1) • Dog Tiredness (lethargy) • Dog

Showing top 5 for Neurologic.

Behavior
Biting -aggression (1) • Dog Behavioral disorder (1) • Dog

Showing top 5 for Behavior.

Effectiveness
Lack of efficacy (endoparasite) - NOS (1) • Dog Lack of efficacy (ectoparasite) - tick NOS (1) • Dog Lack of efficacy (ectoparasite) - flea • Dog

Showing top 5 for Effectiveness.

Other
Weight gain (1) • Dog Syncope (1) • Dog Stomach upset (1) • Dog Polyneuritis (1) • Dog Palpable mass NOS (1) • Dog
Show more (10)
Ocular discharge (1) • Dog Eyelid lump (1) • Dog Drug dose administration interval too short (1) • Dog Drug administration error (1) • Dog Dilated pupils (1) • Dog Death by euthanasia (1) • Dog Cognitive disorder NOS (1) • Dog Blindness (1) • Dog Anterior uveitis (1) • Dog Adipsia (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, ['Retriever - Labrador', 'Terrier (unspecified)'], Male, 5 year, 19.9 kilogram • Drug: MSK, Topical, Dose: 1 collar per unknown • Reactions: Syncope, Stomach upset, Lack of efficacy (ectoparasite) - tick NOS, Drug administration error, Drug dose administration interval too short • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2023-US-011531
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 19.900 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Topical
  • Dose: 1 collar per unknown
Reactions Reported:
Syncope Stomach upset Lack of efficacy (ectoparasite) - tick NOS Drug administration error Drug dose administration interval too short
Outcomes: Outcome Unknown

Dog, Dachshund (unspecified), Male, 1 year, 9.5 kilogram • Drug: MSK, Topical, Dose: 1 collar per unknown • Reactions: Syncope, Stomach upset, Lack of efficacy (ectoparasite) - tick NOS, Cognitive disorder NOS, Death by euthanasia… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2023-US-011351
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 1.00 Year
  • Weight: 9.500 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Topical
  • Dose: 1 collar per unknown
Reactions Reported:
Syncope Stomach upset Lack of efficacy (ectoparasite) - tick NOS Cognitive disorder NOS Death by euthanasia Behavioral disorder (unspecified) Biting -aggression Drug administration error
Outcomes: Euthanized

Dog, Retriever - Labrador, Female, 8 year, 42.365 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - NOS, Ocular discharge, Weight gain, Eyelid lump, Palpable mass NOS • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2021-US-044720
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 8.00 Year
  • Weight: 42.365 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Lack of efficacy (endoparasite) - NOS Ocular discharge Weight gain Eyelid lump Palpable mass NOS
Outcomes: Ongoing

Dog, Bulldog - French, Male, 5 month • Drug: MSK, Solution, Topical • Reactions: Dilated pupils, Unsteady walking (ataxia), Blindness, Anterior uveitis, Polyneuritis • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2018-US-045794
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 5.00 Month
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Topical
  • Form: Solution
Reactions Reported:
Dilated pupils Unsteady walking (ataxia) Blindness Anterior uveitis Polyneuritis
Outcomes: Ongoing

Dog, Terrier - Bull, Female, 5 month, 10.433 kilogram • Drug: MSK, Solution, Topical, Dose: 1 dose per animal • Reactions: Loss of appetite, Adipsia, Tiredness (lethargy) • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2018-US-019263
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 5.00 Month
  • Weight: 10.433 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Topical
  • Form: Solution
  • Dose: 1 dose per animal
Reactions Reported:
Loss of appetite Adipsia Tiredness (lethargy)
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.